ArticleFrontiers in oncology2023

Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study.

Jianghua Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.